Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy
Authors:
Open Access
- 5 June 2025
- journal article
- review article
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 107, 101377
Abstract
No abstract availableKeywords
This publication has 185 references indexed in Scilit:
- Safety and Vision Outcomes Following Gene Therapy for Bietti Crystalline DystrophyJAMA Ophthalmology, 2025
- Clinical and genetic characterization of a large cohort of Chinese patients with Bietti crystalline retinopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2023
- Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene VariationsJAMA Ophthalmology, 2023
- Retinitis Pigmentosa (Non-syndromic)2018
- Novel insights into the molecular pathogenesis ofCYP4V2‐associated Bietti's retinal dystrophyMolecular Genetics & Genomic Medicine, 2014
- Dietary ω-3 Fatty Acid and Fish Intake and Incident Age-Related Macular Degeneration in WomenArchives of Ophthalmology (1950), 2011
- Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)Human Mutation, 2006
- Development of the 25-list-item National Eye Institute Visual Function QuestionnaireArchives of Ophthalmology (1950), 2001
- Identification, Isolation, and Characterization of a 32-kDa Fatty Acid-Binding Protein Missing from Lymphocytes in Humans with Bietti Crystalline Dystrophy (BCD)Molecular Genetics and Metabolism, 1998
- Bietti's Crystalline DystrophyArchives of Ophthalmology (1950), 1989